BIOMAT Database Logo BIOMAT Database Logo

[X-ray prevention of gynecomastia in prostatic carcinoma patients during estrogen therapy]. 1967

O S Alfthan, and L R Holsti

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D006177 Gynecomastia Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males. Adolescent Gynecomastia,Infant Gynecomastia,Male Breast Enlargement,Newborn Gynecomastia,Breast Enlargement, Male,Enlargement, Male Breast,Gynecomastia, Adolescent,Gynecomastia, Infant,Gynecomastia, Newborn
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

O S Alfthan, and L R Holsti
[Prevention of the gynecomastia by x-ray irradiation of the mamilla (mamma virile) in patients with prostatic carcinoma treated with hormones].
January 1968, Der Urologe,
O S Alfthan, and L R Holsti
Prevention of platelet aggregation in patients with prostatic cancer during estrogen therapy.
June 1982, Urology,
O S Alfthan, and L R Holsti
[Gynecomastia as a complication of estrogen therapy of prostatic cancer].
January 1973, Urologiia i nefrologiia,
O S Alfthan, and L R Holsti
Estrogen therapy in prostatic carcinoma.
January 1950, Acta radiologica,
O S Alfthan, and L R Holsti
Radical treatment of prostatic carcinoma by megavoltage X-ray therapy.
September 1986, Clinical radiology,
O S Alfthan, and L R Holsti
[X-ray examinations of prostatic adenoma and carcinoma].
January 1986, Radiologia diagnostica,
O S Alfthan, and L R Holsti
[Cardiovascular complications during the estrogen therapy of prostatic cancer patients].
January 1985, Urologiia i nefrologiia,
O S Alfthan, and L R Holsti
[Irradiation for prevention of gynecomastia prior to estrogen therapy in cases of carcinoma of the prostate (author's transl)].
March 1977, Der Urologe. Ausg. A,
O S Alfthan, and L R Holsti
Prevention of body fluid retention by furosemide during estrogen therapy of prostatic cancer.
August 1975, The Journal of urology,
O S Alfthan, and L R Holsti
[Prophylactic irradiation of the breast for the prevention of gynecomastia during the hormonal therapy of prostatic cancer].
January 1973, Urologiia i nefrologiia,
Copied contents to your clipboard!